Our Co-CEO AmirAli Talasaz caught up with FierceBiotech at the Milken Institute Global Conference where he discussed our upcoming FDA advisory panel review for Shield, our blood-based screening test for #ColorectalCancer .
fiercebiotech.com/medtech/guarda…

A breathtaking sight over our laboratory in Redwood City.

#AuroraBorealis #NorthernLights

Today, we announced our first quarter financial results and updated guidance for the year.

Full release: investors.guardanthealth.com/press-releases…

Great event highlighting the future of #Cancer care. Thank you John Joyce, M.D. for mentioning blood based CRC screening tests and to Danielle Carnival for your work with the #Cancer Moonshot.

We're honored to (again) be certified as a #GreatPlaceToWork ! This recognition is a testament to our people, who dedicate themselves to foster our diverse, inclusive and mission-driven culture.

Join us: guardanthealth.com/careers/

#GPTWcertified

Triumphant Warrior is warming the feet - and hearts - of patients at UT Health Austin’s Surgical Oncology Clinic through the gift of fun socks, which were distributed by Guardant Health! Learn more about the Surgical Oncology Clinic care team: uthealthaustin.org/clinics/cancer…

This morning we announced that our research has reached a new milestone: 500 peer-reviewed publications featuring Guardant's technology in esteemed scientific journals.

Full release: investors.guardanthealth.com/press-releases…

We're honored to be recognized by the #BidenCancerMoonshot and look forward to partnerships with the Cancer Cabinet and key stakeholder groups like First Ladies Health + Ballad Health to help close the screening gap by ensuring access to new screening tech.

bit.ly/4biXay3

Come visit us at the upcoming #ISPORAnnual from May 5 - 8 in Atlanta, where we will share four posters highlighting our GuardantINFORM real-world clinical-genomic database.

Our co-CEO Helmy Eltoukhy participated tonight in STAT in DC: Policy in Health Care, where he discussed the role of liquid biopsies in closing the gap in cancer care and the essential need for collaboration to overcome regulatory & reimbursement challenges for emerging tech.

The CRC community lost a true champion today. Donald Payne Jr. never stopped advocating on behalf of patients for policies that helped drive innovation and access. Thank you for your leadership and may you rest in peace.

Join our SVP of Global Public Affairs Jenn Higgins for a powerful discussion on the stigmas surrounding #LungCancer and the importance of equitable access to care pathways in partnership with Lung Cancer Policy Network and Lung Ambition Alliance.

▶️ : youtube.com/watch?v=WD2_NF…

Earlier today we announced an FDA advisory panel meeting to review our premarket approval application for our Shield blood test is scheduled for May 23rd.

Read more: investors.guardanthealth.com/press-releases…

As part of Milken Institute's Power of Ideas series, our co-CEO Helmy Eltoukhy shares his perspective on the critical role liquid biopsies have in addressing access gaps in health care.

milkeninstitute.org/article/health…

We're proud to sponsor the #CongressionalFamilies Cancer Prevention Program and Prevent Cancer Foundation reception honoring Dr. Collins! Great to see HHS Secretary Xavier Becerra and Rosa DeLauro speak passionately about cancer screening ⁦innovation and patient access.

Join us as we celebrate the dedicated medical laboratory professionals evolving #PatientCare and expanding diagnostic testing with the meaningful work they do everyday, including in our mission to conquer #Cancer with data.

#LabWeek #TheFutureIsLab

Great thought leadership about the promise of #PersonalizedCare . As members of the Personalized Medicine Coalition, we're committed to bridging the gap between current scientific breakthroughs to bring more access and care to patients.

statnews.com/2024/04/05/per…

Feels like a good day for a reminder that our #ECLIPSE study data showcasing the effectiveness of our Shield blood test for detecting #ColorectalCancer was recently published in The New England Journal of Medicine.

More details: investors.guardanthealth.com/press-releases…

Happy viewing everyone 😎

We’re ready for another exciting day of inspiring interactions, presentations and discussions with the #CancerResearch community at  #AACR24 . Stop by booth #3545 to say hello and learn how our solutions can help advance your research.

PharmaTimes highlights our partnership with The Royal Marsden NHS Foundation Trust aimed at helping thousands of #LungCancer patients across the UK.

pharmatimes.com/news/study-rev…